A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity

Danielle L Swaney1,2,3,4, Dana J Ramms4,5,6, Zhiyong Wang4,6

  • 1Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.

Science (New York, N.Y.)
|September 30, 2021
PubMed

Insights

This study introduces a new framework using protein maps to understand head and neck cancer. It identified new interactions that drive cancer cell migration and inform treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Tumor genetic complexity presents a significant challenge in understanding cancer biology.
  • Head and neck squamous cell carcinoma (HNSCC) requires novel approaches for molecular characterization.

Purpose of the Study:

  • To develop and apply a framework for elucidating tumor genetic complexity using multidimensional protein-protein interaction (PPI) maps.
  • To enhance the understanding of HNSCC by identifying key molecular interactions and pathways.

Main Methods:

  • Construction of multidimensional PPI networks integrating data from cancer and noncancerous cell states.
  • Analysis of wild-type (WT) and mutant protein isoforms within the PPI network.
  • Prioritization of cancer-enriched and mutation-enriched interactions.

Main Results:

  • The PPI network revealed 771 interactions, including WT and mutant protein isoforms.
  • A novel association was identified between fibroblast growth factor receptor tyrosine kinase 3 (FGFR3) and Daple, activating Gαi and p21-activated protein kinase 1/2 (PAK1/2) to promote HNSCC cell migration.
  • Mutation-enriched interactions between human epidermal growth factor receptor 3 (HER3) and PIK3CA were observed, offering insights into HER3 inhibition efficacy.

Conclusions:

  • The developed framework provides a powerful tool for translating genetic alterations into molecular and clinical insights.
  • The identified FGFR3-Daple and HER3-PIK3CA interactions offer new therapeutic targets and predictive biomarkers for HNSCC.
  • This approach is anticipated to be valuable across various disease areas for understanding underlying molecular biology.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K